tirzepatide and hypertension blood pressure reduction: stratified analyses of the SURMOUNT-1 randomised controlled trial Tirzepatide Blood Pressure Reduction: Clinical

Her anxiety melted away

New side effect of GLP-1 drugs In a study published on Wednesday, in JAMA Otolaryngology, researchers analysed medical records from more than 2 million patients collected across the country between 2005 and 2025

Serum total L-carnitine levels in non-obese women with polycystic ovary syndrome

Dynamic shifts in the composition of resident and recruited macrophages influence tissue remodeling in NASH

Y., Zhang, X

In SUSTAIN 6 the preapproval CVOT for subcutaneous semaglutide the rate of CV death, nonfatal myocardial infarction, or nonfatal stroke was significantly lower among patients receiving semaglutide (6.6% [108/1,648]) than among those receiving placebo (8.9% [146/1,649]